Synthetic biology and genome-editing technologies hold promise to provide rapid, accurate, flexible diagnostics for established, evolving, and emerging pathogens. Therefore, we develop synthetic biology technologies for molecular diagnostics of pathogens and disease markers. We design, build, and develop point-of-care detection modules for nucleic acid diagnostics for different human and non-human pathogens.
